Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Gabriella Matera

Showing results (31-40 of 324) with videos related to

Pageof 33
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|January 22, 2016
Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Alessandro Sanduzzi, Mario Cazzola
Expert Review of Respiratory Medicine|November 17, 2015
Oxidation pathway and exacerbations in COPD: the role of NACMaria Gabriella Matera, Luigino Calzetta, Mario Cazzola
Pulmonary Pharmacology & Therapeutics|October 27, 2009
TNF-alpha inhibitors in asthma and COPD: we must not throw the baby out with the bath waterMaria Gabriella Matera, Luigino Calzetta, Mario Cazzola
Expert Opinion on Pharmacotherapy|April 7, 2015
QVA149 (indacaterol/glycopyrronium) for the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Paola Rogliani, Mario Cazzola
The Journal of Allergy and Clinical Immunology|July 1, 2020
The latest on the role of LAMAs in asthmaMario Cazzola, Paola Rogliani, Maria Gabriella Matera
The Lancet. Respiratory Medicine|December 9, 2024
Evaluating tezepelumab for COPD: a missed target or unmet potential?Mario Cazzola, Paola Rogliani, Maria Gabriella Matera
Therapeutics and Clinical Risk Management|December 18, 2015
Differential pharmacology and clinical utility of long-acting bronchodilators in COPD - focus on olodaterolMaria Gabriella Matera, Josuel Ora, Mario Cazzola
Current Opinion in Pharmacology|December 17, 2020
Prospects for COPD treatmentMaria Gabriella Matera, Mario Cazzola, Clive Page
Respiratory Medicine|August 20, 2019
Ultra-LABAs for the treatment of asthmaMario Cazzola, Paola Rogliani, Maria Gabriella Matera
Immunology and Allergy Clinics of North America|August 14, 2022
Unmet Needs and the Future of Asthma-Chronic Pulmonary Obstructive Disease OverlapMario Cazzola, Paola Rogliani, Maria Gabriella Matera
Pageof 33

Showing results (31-40 of 324) with videos related to

Sort By:
Pageof 33
International Journal of Chronic Obstructive Pulmonary Disease|January 22, 2016
Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Alessandro Sanduzzi, Mario Cazzola
Expert Review of Respiratory Medicine|November 17, 2015
Oxidation pathway and exacerbations in COPD: the role of NACMaria Gabriella Matera, Luigino Calzetta, Mario Cazzola
Pulmonary Pharmacology & Therapeutics|October 27, 2009
TNF-alpha inhibitors in asthma and COPD: we must not throw the baby out with the bath waterMaria Gabriella Matera, Luigino Calzetta, Mario Cazzola
Expert Opinion on Pharmacotherapy|April 7, 2015
QVA149 (indacaterol/glycopyrronium) for the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Paola Rogliani, Mario Cazzola
The Journal of Allergy and Clinical Immunology|July 1, 2020
The latest on the role of LAMAs in asthmaMario Cazzola, Paola Rogliani, Maria Gabriella Matera
The Lancet. Respiratory Medicine|December 9, 2024
Evaluating tezepelumab for COPD: a missed target or unmet potential?Mario Cazzola, Paola Rogliani, Maria Gabriella Matera
Therapeutics and Clinical Risk Management|December 18, 2015
Differential pharmacology and clinical utility of long-acting bronchodilators in COPD - focus on olodaterolMaria Gabriella Matera, Josuel Ora, Mario Cazzola
Current Opinion in Pharmacology|December 17, 2020
Prospects for COPD treatmentMaria Gabriella Matera, Mario Cazzola, Clive Page
Respiratory Medicine|August 20, 2019
Ultra-LABAs for the treatment of asthmaMario Cazzola, Paola Rogliani, Maria Gabriella Matera
Immunology and Allergy Clinics of North America|August 14, 2022
Unmet Needs and the Future of Asthma-Chronic Pulmonary Obstructive Disease OverlapMario Cazzola, Paola Rogliani, Maria Gabriella Matera
Pageof 33